[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100594278":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":27,"locations":33,"responsibleParty":44,"collaborators":48,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":11,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":11,"enrollmentInfo":62,"targetDuration":11,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":72,"overallStatus":73,"whyStopped":11,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Seoul National University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Conventional","ACTIVE_COMPARATOR",null,[13],"Procedure: Conventional",{"label":15,"type":16,"description":11,"interventionNames":17},"ERAS","EXPERIMENTAL",[18],"Procedure: ERAS",[20,24],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":11},"PROCEDURE","Pre-operative fasting: NPO for solids and fluids from 00:00. No pre-emptive oral analgesia. Intra-operative: IV dexamethasone 5 mg at anaesthesia induction; IV acetaminophen 1 g about 1 h before wound closure. Post-operative nutrition: Levin tube removed in OR. POD1 morning-sips of water; POD3 morning upright abdominal X-ray; if normal, start soft fluid diet POD3 evening. POD4 pancreatobiliary CT; if normal, start soft bland diet at lunch. Drain management: two drains at hepaticojejunostomy and pancreaticojejunostomy; drain amylase measured POD1, 3 and 5; if POD4 CT normal, drains removable from POD5 per surgeon discretion (output, fever, pain). Analgesia: IV PCA until ≈POD3, then oral acetaminophen 650 mg every 8 h. No carbohydrate loading or NSAID\u002Fnefopam adjuncts.",[9],{"type":21,"name":15,"description":25,"armGroupLabels":26,"otherNames":11},"Pre-op fasting: solids NPO from 00:00; clear fluids until 3 h pre-op; 300 mL carbohydrate drink 2-4 h pre-op with oral acetaminophen 650 mg + zaltoprofen 80 mg. Intra-op: IV dexamethasone 8 mg at induction; IV acetaminophen 1 g + ibuprofen 300 mg + nefopam 20 mg 1 h before closure. Post-op nutrition: Levin tube removed in OR. POD1 sips of water; POD2 morning upright abdominal X-ray-if normal, start soft fluid diet POD2 evening. POD3 pancreatobiliary CT-if normal, start soft bland diet at lunch. Drain mgmt: same placement; amylase POD1 \\& 3; if POD4 CT normal and amylase ≤ 5 000 U\u002FL trending down, remove drains POD4; otherwise per surgeon. Analgesia: IV PCA until ≈POD3; until POD1 morning, IV acetaminophen 1 g + ibuprofen 300 mg q8h; POD1-5, oral acetaminophen 650 mg + zaltoprofen 80 mg q8h.",[15],[28],{"name":29,"role":30,"phone":31,"phoneExt":11,"email":32},"Young Jae Cho, M.D.","CONTACT","+821023783631","whdudwo85@naver.com",[34],{"facility":5,"status":11,"city":35,"state":36,"zip":37,"country":38,"countryCode":11,"cosmosGeoPoint":11,"geoPoint":11,"contacts":39},"Daehak-ro, Jongno-gu","Seoul","03080","South Korea",[40],{"name":41,"role":30,"phone":42,"phoneExt":11,"email":43},"Hyo-Jin Lee","+821039538452","ash0324@snu.ac.kr",{"type":45,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Wooil Kwon","Associate Professor",[49,51],{"name":50,"class":6},"SMG-SNU Boramae Medical Center",{"name":52,"class":6},"Korea University Anam Hospital","100594278","eras-program-implementation-for-mipd-100594278",false,"NCT07017361","ERAS Program Implementation for MIPD","A Multicenter Randomized Prospective Study on Establishing an ERAS Program and Optimized Clinical Protocol for Patients Undergoing Minimally Invasive Pancreatoduodenectomy (MIPD)","Inclusion Criteria:\n\n* Age ≥ 19 years, scheduled for standard minimally invasive (robotic or laparoscopic) pancreatoduodenectomy for periampullary tumors\n* ECOG performance status of 0 or 1 at screening\n* Able to provide written informed consent, understand study procedures, and complete patient-reported questionnaires\n* ASA physical status classification I-III\n\nExclusion Criteria:\n\n* Hypersensitivity to fentanyl or ropivacaine\n* Cognitive impairment preventing independent use of patient-controlled analgesia or completion of questionnaires\n* Major internal medical or psychiatric disorders affecting treatment response\n* Severe hepatic or renal dysfunction\n* Any condition deemed inappropriate for study participation by the investigator","ALL","19 Years",{"count":63,"type":64},140,"ESTIMATED","INTERVENTIONAL",[67],"NA","To evaluate the impact of an Enhanced Recovery After Surgery (ERAS) program on postoperative recovery in patients undergoing minimally invasive pancreatoduodenectomy (MIPD)",[70,15,71],"Pancreaticoduodenectomy","Minimally Invasive Surgery",[70,15,71],"NOT_YET_RECRUITING","2025-06-14",{"date":76,"type":77},"2025-06-17","ACTUAL",{"date":79,"type":64},"2025-07-15",{"date":81,"type":64},"2027-12-31",{"name":5,"class":6},1]